I have about 3300 reads from foxmid library and I'd like to maping to a reference sequence, how should I do? I also have some solexa data to improve my sequence quality. Can I use the some software to map or different?
Unconfigured Ad
Collapse
X
-
Tags: None
-
Yes, I have tried. However, I do not satisfied with the results. I'd like to know some beter way to mapping the reads.
Comment
-
SHRiMP will happily align both your Solexa and Sanger reads to your reference sequence, allowing for both indels and substitutions: http://compbio.cs.toronto.edu/shrimp/Originally posted by anyone1985 View PostI have about 3300 reads from foxmid library and I'd like to maping to a reference sequence, how should I do? I also have some solexa data to improve my sequence quality. Can I use the some software to map or different?
I have used it for Solexa, SOLID3, Sanger and 454 data with success.
Comment
-
Thank you for your answer. Can the SHRiMP output the result in the format of ace? I would like to calculate the sequence quality, too.
Originally posted by Torst View PostSHRiMP will happily align both your Solexa and Sanger reads to your reference sequence, allowing for both indels and substitutions: http://compbio.cs.toronto.edu/shrimp/
I have used it for Solexa, SOLID3, Sanger and 454 data with success.
Comment
-
You might want to try MIRA, it'll happily map Sanger, 454 and Solexas for you and shell out the results as FASTA, CAF, ACE ... . Screenshot of 454 and Sanger reads mapped to a reference: http://chevreux.org/mira_ex_454sanger.htmlOriginally posted by anyone1985 View PostYes, I have tried. However, I do not satisfied with the results. I'd like to know some beter way to mapping the reads.
B.
Disclaimer: I may be biased, I wrote MIRA.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment